Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21904,193,0.88 [0.66-1.16],0.3665180911563642
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23118,253,0.78 [0.62-0.98],0.0316733935411553
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22842,1755,0.78 [0.72-0.85],3.677438550398495e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,23124,549,0.89 [0.75-1.05],0.1575550937122343
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22365,4230,0.83 [0.78-0.88],7.912233709071063e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22310,4314,0.81 [0.76-0.85],1.440885222557749e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22829,1427,0.78 [0.71-0.86],3.211557910205767e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23025,129,0.71 [0.53-0.96],0.0260966626380962
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20303,1305,0.77 [0.69-0.84],1.1665222264037909e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19590,1589,0.73 [0.67-0.79],1.6366471007296802e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19087,343,0.73 [0.61-0.88],0.0010305708369114
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15031,2750,0.76 [0.71-0.82],6.631615919884349e-15
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19014,494,0.73 [0.63-0.86],0.0001369278460877
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23101,1699,0.79 [0.73-0.87],4.102076650096414e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Mycoses,23220,645,0.85 [0.73-0.99],0.0403620246347527
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22333,1246,0.76 [0.69-0.84],1.439377904825507e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23150,1439,0.80 [0.73-0.88],8.39905326043554e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21655,253,0.77 [0.61-0.96],0.0214711723795275
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23280,65,0.91 [0.55-1.50],0.7153801522803056
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22969,1258,0.79 [0.71-0.88],8.170829944473208e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22979,83,0.97 [0.61-1.53],0.8843307979805828
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23215,146,1.06 [0.74-1.52],0.7464844496853765
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23191,122,1.17 [0.77-1.76],0.4636788823262281
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21586,499,0.76 [0.65-0.90],0.0010088055681771
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21393,306,0.81 [0.65-1.00],0.0554683585808466
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21542,140,0.94 [0.66-1.35],0.7473623590020693
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23266,52,0.76 [0.47-1.23],0.2628979325274291
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23210,174,0.79 [0.60-1.04],0.0935792241977516
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral warts,23091,55,0.88 [0.52-1.48],0.6248581146600063
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23116,80,0.79 [0.53-1.19],0.2663751659847033
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm,22986,264,0.84 [0.67-1.05],0.1231852077449812
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23197,40,0.74 [0.43-1.29],0.2896595467584306
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23180,42,1.48 [0.70-3.12],0.3033625885325231
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11083,84,0.76 [0.53-1.08],0.1306220293001671
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22807,1682,0.91 [0.83-1.00],0.061978059629865
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of meninges,23264,65,0.55 [0.40-0.75],0.0001645573195165
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23184,80,0.99 [0.62-1.59],0.9768475441841497
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23254,121,0.78 [0.55-1.09],0.1380061693693809
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of ovary,12126,79,0.85 [0.54-1.34],0.4866001781040313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23240,443,0.78 [0.66-0.92],0.0039108958289796
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Caecum,23245,386,0.81 [0.67-0.98],0.026993492104577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23130,88,0.94 [0.61-1.45],0.7912636551843715
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,23236,254,0.93 [0.73-1.20],0.5873618491045821
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Rectum,23194,407,0.85 [0.70-1.02],0.0795153668041454
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23122,682,0.93 [0.80-1.09],0.3802552905059564
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23222,545,0.92 [0.77-1.09],0.3214427732018322
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Carcinoma in situ of breast,9112,50,1.53 [0.75-3.15],0.2437905689772821
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9154,65,1.12 [0.64-1.98],0.687503350563367
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16601,71,1.35 [0.78-2.34],0.278424856208706
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16629,99,0.85 [0.58-1.25],0.4203718407879253
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23224,126,0.73 [0.54-0.98],0.0365660568894739
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma, any site",23225,124,0.74 [0.54-1.00],0.0512304673244134
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Leiomyoma of uterus,11854,170,1.02 [0.72-1.43],0.9292306584181524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lung cancer and mesothelioma,14737,479,0.71 [0.60-0.84],8.217589312540431e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lymphoid leukaemia,16602,72,1.05 [0.64-1.71],0.8566321378289709
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16755,225,0.79 [0.63-1.00],0.0547640903716465
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16845,315,1.04 [0.82-1.32],0.7323655448236011
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9238,106,1.16 [0.74-1.81],0.5266875374507836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16643,113,0.81 [0.57-1.15],0.243704954527188
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16678,148,0.68 [0.53-0.89],0.0046428869204576
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16654,124,0.99 [0.68-1.44],0.958749092928582
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9220,88,1.12 [0.69-1.82],0.641201004541465
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16658,128,0.88 [0.62-1.24],0.4592122165549526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8377,979,0.93 [0.82-1.05],0.2292218166844832
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16665,135,0.76 [0.56-1.02],0.0666800744042271
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16622,92,1.33 [0.82-2.15],0.2516534166430665
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16677,147,1.25 [0.86-1.82],0.2437655656937
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi,23130,186,1.05 [0.76-1.43],0.7827739509327676
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi of trunk,23251,79,0.84 [0.55-1.27],0.4128081891969608
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanoma in situ,16583,112,0.80 [0.57-1.13],0.2098931849027587
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16652,122,0.94 [0.65-1.35],0.7306942840995891
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16732,202,0.91 [0.69-1.20],0.4989710631537167
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16854,324,0.76 [0.62-0.93],0.0071233753432602
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16659,129,0.89 [0.63-1.26],0.5081511574739106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Other benign neoplasms of skin,23103,163,0.91 [0.67-1.24],0.5597574725633738
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18029,1499,0.93 [0.84-1.03],0.1493322108047342
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18115,1585,0.92 [0.84-1.02],0.1240774278579809
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22968,398,0.84 [0.70-1.02],0.0804198162010994
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20942,165,0.84 [0.62-1.13],0.2447413015719665
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22643,73,0.81 [0.53-1.25],0.3467585067543774
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22506,3528,0.80 [0.75-0.85],3.249063069149825e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21540,73,0.60 [0.42-0.86],0.0050699774932632
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22804,65,0.71 [0.47-1.06],0.0954161706322997
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22757,1980,0.77 [0.71-0.83],2.161976129048016e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22755,1978,0.77 [0.71-0.84],2.4616321911242313e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20893,116,0.85 [0.60-1.20],0.3488908454483403
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22914,1447,0.78 [0.71-0.86],4.1199242369650733e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22854,115,0.73 [0.53-1.01],0.057654061647747
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22645,75,0.93 [0.58-1.48],0.7530892654871619
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22646,76,1.12 [0.68-1.86],0.6488474910723093
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23096,357,0.85 [0.70-1.04],0.1136445025390265
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23149,40,0.83 [0.46-1.48],0.519833204313136
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23034,295,0.88 [0.70-1.11],0.2830782488179234
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21606,139,0.65 [0.50-0.85],0.0019069878288988
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15557,414,0.66 [0.56-0.79],2.336916853483714e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21764,104,0.73 [0.52-1.02],0.061664952701498
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21773,113,0.55 [0.43-0.71],3.09007123454418e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15212,69,0.57 [0.40-0.82],0.0022031762966087
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21624,64,0.77 [0.49-1.21],0.2622966045169134
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20832,321,0.78 [0.63-0.96],0.0179005446877232
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22478,964,0.83 [0.73-0.94],0.0027527604014481
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22002,488,1.19 [0.96-1.46],0.109160714412955
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21733,219,0.82 [0.64-1.06],0.1302936156504124
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22993,1433,0.90 [0.81-1.00],0.0547746541393255
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19587,1389,0.88 [0.79-0.98],0.0248585971261896
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15237,94,0.71 [0.49-1.02],0.0636587585813115
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20983,101,0.64 [0.47-0.87],0.0042922920779008
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15514,371,0.65 [0.54-0.77],9.88146434571459e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15200,57,1.18 [0.64-2.16],0.5925239342361983
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19773,4630,0.86 [0.81-0.92],9.045219283663464e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15411,268,0.57 [0.47-0.69],2.919263952884289e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15863,720,0.71 [0.63-0.82],8.096454626434451e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23219,374,0.80 [0.66-0.97],0.0222186875997955
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23008,163,0.86 [0.63-1.17],0.3233773609226333
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15298,155,0.90 [0.65-1.26],0.5401897145907228
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15225,82,0.52 [0.39-0.71],2.022036470103251e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22641,1759,0.92 [0.84-1.02],0.1064579989806196
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15532,389,0.61 [0.51-0.72],3.428348211212474e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15574,431,0.63 [0.54-0.74],2.3867316343099853e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16012,869,0.74 [0.65-0.83],6.477267425546225e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15320,177,1.12 [0.80-1.58],0.5159775938546924
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22998,153,0.89 [0.64-1.23],0.4661730397807058
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16045,902,0.71 [0.63-0.80],1.2001093246848844e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15807,664,0.63 [0.56-0.72],1.3636944824713485e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20592,81,0.69 [0.48-1.00],0.0483083148237976
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21623,6480,0.85 [0.81-0.89],3.3713611918805997e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20943,61,0.72 [0.45-1.13],0.1474926546998539
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20931,49,0.88 [0.49-1.57],0.664180085803657
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23093,1916,0.84 [0.77-0.91],6.491631355892001e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23091,1914,0.84 [0.77-0.91],7.989330562595402e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20946,64,0.75 [0.48-1.18],0.2173512857117001
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22923,1143,0.85 [0.76-0.95],0.0051746469852429
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17395,2252,0.70 [0.65-0.75],8.2502421725379185e-22
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23264,315,0.89 [0.71-1.12],0.3289479387590736
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21644,130,1.29 [0.86-1.94],0.2189282831505182
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21900,120,0.80 [0.57-1.12],0.1900030659170507
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21946,166,1.08 [0.76-1.52],0.6691214666153722
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15344,201,0.71 [0.55-0.91],0.0075106649792881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20464,187,1.03 [0.76-1.42],0.8307694244418423
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2496,99,0.86 [0.57-1.29],0.4630682524309123
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2665,309,0.83 [0.66-1.04],0.1120079268388538
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20361,84,0.77 [0.52-1.15],0.2038732972024378
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2470,76,0.61 [0.42-0.91],0.0145906573508847
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22429,2152,0.97 [0.89-1.07],0.5741643240239895
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22151,637,0.83 [0.71-0.97],0.0181873547716765
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20966,455,0.99 [0.81-1.21],0.9212589701846732
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16266,1123,0.74 [0.66-0.83],1.6212604873334609e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23142,306,0.68 [0.57-0.82],4.463683155490047e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21767,271,0.72 [0.59-0.89],0.0024372054206947
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Angina pectoris,20104,1577,0.81 [0.74-0.89],1.4990649777882578e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21873,377,0.67 [0.57-0.79],2.200869605652817e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21584,88,0.60 [0.44-0.84],0.0025453891297892
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21793,297,0.64 [0.53-0.78],4.456346042843437e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11790,2862,0.80 [0.74-0.85],1.1019516408682078e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,AV-block,17677,682,0.76 [0.66-0.87],6.530502767641659e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23194,583,0.90 [0.77-1.06],0.2239144813500247
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,9192,264,0.64 [0.53-0.78],7.146568938557652e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17202,207,0.80 [0.62-1.04],0.0984209631136719
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17107,112,0.86 [0.59-1.24],0.4113215161540439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23274,81,0.62 [0.44-0.86],0.0050127627807491
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Conduction disorders,18567,1572,0.77 [0.70-0.84],1.1410324881874212e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21272,2770,0.83 [0.78-0.90],6.850267376324497e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18690,8962,0.91 [0.87-0.95],2.141017380435236e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21688,337,0.71 [0.59-0.85],0.000231047418451
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Endocarditis,17097,102,0.68 [0.49-0.94],0.0189002506982424
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22990,1679,0.72 [0.66-0.79],3.3366825826281675e-14
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,19939,7976,0.89 [0.86-0.94],8.774263813343173e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19958,7995,0.90 [0.86-0.94],1.267208447669663e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23103,99,1.13 [0.73-1.75],0.5940802461103147
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12224,261,0.63 [0.52-0.76],1.0820255733720405e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12172,209,0.65 [0.52-0.81],0.0001398073939321
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypotension,23093,1662,0.77 [0.70-0.84],5.966062794280504e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21978,149,0.88 [0.64-1.21],0.4356467372600283
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21448,2921,0.84 [0.79-0.91],2.2963956458570084e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22761,805,0.90 [0.78-1.04],0.1539375639815514
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17522,527,0.78 [0.67-0.92],0.0031431736755592
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22587,1065,0.84 [0.74-0.94],0.0024477673218016
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19444,917,0.80 [0.71-0.90],0.0002786540182424
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23148,190,0.80 [0.62-1.05],0.1062844272691981
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23236,409,0.85 [0.70-1.02],0.0809341036557374
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,21420,69,0.82 [0.52-1.29],0.3835309074987368
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other aneurysm,21603,107,0.62 [0.47-0.83],0.0011422982355413
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,17595,600,0.90 [0.76-1.06],0.2033014413847158
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21633,137,0.62 [0.47-0.81],0.0004390584553272
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21831,335,0.79 [0.64-0.96],0.0192496291295889
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17217,222,0.73 [0.58-0.93],0.0091271848277802
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,21472,121,0.74 [0.54-1.03],0.071851141251128
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21399,48,0.85 [0.49-1.49],0.5759855123593269
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21207,90,1.09 [0.69-1.72],0.7107762141792963
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21533,182,0.68 [0.53-0.87],0.0021367141174859
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18472,1477,0.73 [0.67-0.80],9.138616434752806e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21493,62,1.18 [0.67-2.08],0.574302485049736
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22230,734,0.73 [0.64-0.83],1.456458059438448e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22506,531,0.67 [0.58-0.77],3.80823603469904e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22101,984,0.80 [0.71-0.91],0.0003612968319047
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9344,416,0.68 [0.58-0.79],7.485813501025174e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22061,600,0.72 [0.63-0.84],1.4593720979270911e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21777,426,0.75 [0.64-0.89],0.0010786952883335
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22574,599,0.84 [0.72-0.99],0.0328159023239979
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23179,978,0.78 [0.69-0.87],1.8171753141931472e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17517,522,0.70 [0.61-0.81],1.6308363571751958e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22500,525,0.66 [0.58-0.76],1.332528229387488e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21386,269,0.75 [0.60-0.93],0.007984931109146
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22745,916,0.90 [0.79-1.02],0.1083860946325193
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22730,957,0.92 [0.81-1.05],0.1987949516410195
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21945,63,1.53 [0.83-2.82],0.1779007925995544
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21603,107,0.66 [0.49-0.89],0.0066665091354939
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22282,326,0.96 [0.77-1.21],0.7513106884071051
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21856,334,0.74 [0.61-0.90],0.0022382560834917
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Varicose veins,21873,522,0.90 [0.76-1.07],0.2457499637605414
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21518,121,0.64 [0.48-0.86],0.0027761554649379
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23000,948,0.81 [0.72-0.92],0.0009765306881385
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23196,334,0.68 [0.57-0.81],2.0700137515990723e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19890,1392,0.86 [0.77-0.95],0.0042879262648726
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,22743,4245,0.87 [0.82-0.92],5.227310349984303e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23167,393,0.69 [0.59-0.82],1.3621920646289665e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19959,1461,0.87 [0.78-0.97],0.0087031711224595
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18585,87,0.79 [0.53-1.20],0.2700165599936411
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Smoking dependency,22763,1187,0.81 [0.72-0.90],0.000203478653475
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19957,1459,0.78 [0.71-0.86],2.830854257690477e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Vascular dementia,22369,231,0.68 [0.55-0.84],0.0004589226271363
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Alzheimer disease,23276,598,1.03 [0.87-1.23],0.7159783430058716
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14254,112,1.25 [0.80-1.94],0.3222567577715292
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Bell's palsy,21416,86,0.75 [0.51-1.10],0.1374273954692978
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21825,495,0.95 [0.79-1.15],0.6048576516152896
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral cysts,22821,251,0.74 [0.60-0.92],0.0069268420304463
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23202,414,0.79 [0.66-0.95],0.0116744806978098
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22419,76,1.07 [0.66-1.75],0.783103794488309
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23260,69,0.78 [0.51-1.18],0.2381257602068863
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22658,88,0.62 [0.46-0.85],0.00304570996321
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Epilepsy,21754,308,0.84 [0.68-1.04],0.1160898467956229
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22810,1364,0.90 [0.81-1.00],0.0433196739743973
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23222,926,0.88 [0.78-1.00],0.0555818602881797
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22613,3478,0.82 [0.77-0.88],2.007568848393513e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,22890,54,0.77 [0.47-1.25],0.2862733132394513
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hemiplegia,23128,340,0.81 [0.66-1.00],0.0457574104459627
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hydrocephalus,22644,74,0.97 [0.60-1.58],0.9111488219599728
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23263,74,1.09 [0.65-1.81],0.7519731205847242
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21397,67,0.63 [0.44-0.90],0.0108735498848845
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21404,74,0.88 [0.56-1.38],0.5877526111248201
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Memory loss,22118,143,1.17 [0.80-1.71],0.4116651932434725
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Migraine,21729,283,1.12 [0.86-1.46],0.4073904246570761
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23229,259,1.11 [0.84-1.46],0.476670137042095
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Motor neuron disease,14340,174,1.01 [0.73-1.39],0.9611439614376046
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23144,62,0.77 [0.49-1.22],0.2651566880333721
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22564,1234,0.93 [0.83-1.05],0.2285803859711091
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Neurological diseases,21780,4389,0.92 [0.87-0.98],0.0076669948500296
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22666,323,0.96 [0.77-1.22],0.7598526813644159
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21757,427,0.87 [0.72-1.05],0.1578420986806005
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23199,351,0.92 [0.74-1.14],0.4240644788092733
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17407,984,0.95 [0.83-1.08],0.4199149264478676
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22658,88,0.73 [0.51-1.05],0.0870419750524188
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22732,162,0.90 [0.66-1.23],0.5009321970447382
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22529,233,0.86 [0.66-1.10],0.2332871339469243
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21427,97,0.82 [0.56-1.19],0.2969749316644956
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other headache syndromes,21499,53,1.23 [0.65-2.31],0.5290472081940462
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other neurological diseases,23160,590,0.79 [0.68-0.92],0.0025843712268433
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other sleep disorders,21967,521,0.80 [0.69-0.94],0.0062076712529837
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Parkinson's disease,23243,688,0.86 [0.75-1.00],0.0514878151669632
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22617,47,0.65 [0.42-1.01],0.0560218270953255
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,23277,104,0.94 [0.63-1.41],0.7695995283767962
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Sleep apnoea,23046,442,0.79 [0.67-0.94],0.0070161752225516
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22910,62,1.19 [0.67-2.11],0.547520565235456
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23265,203,1.04 [0.77-1.39],0.812377009286188
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21400,70,1.10 [0.65-1.87],0.7226742061417144
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23276,604,1.04 [0.87-1.24],0.69243749089276
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22307,225,0.73 [0.57-0.92],0.007454427950081
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22626,158,0.80 [0.60-1.08],0.1425477977221991
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22814,566,0.97 [0.82-1.16],0.7716343964816264
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23021,268,0.77 [0.61-0.96],0.0183079491816114
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22037,69,1.03 [0.62-1.71],0.9209451945007052
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22005,37,0.98 [0.50-1.93],0.9626365805858444
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23153,75,0.69 [0.47-1.01],0.0587363542040277
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22957,226,1.11 [0.83-1.49],0.4835927048029235
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2474,77,0.62 [0.42-0.91],0.01423692002373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3048,112,0.93 [0.63-1.39],0.7340524514388499
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22578,110,0.90 [0.62-1.31],0.5683474149359087
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22976,1434,0.91 [0.82-1.01],0.0680763813582819
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22857,889,0.96 [0.83-1.10],0.5202381707423055
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22272,304,0.93 [0.73-1.17],0.5338662819676743
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23201,953,1.02 [0.89-1.17],0.7766210011986343
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23270,80,0.93 [0.59-1.47],0.7707354157658521
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23128,880,1.00 [0.87-1.15],0.995098562261168
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23233,502,0.90 [0.75-1.07],0.2400397049097995
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23155,229,1.17 [0.87-1.58],0.2912834912428445
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22071,103,1.16 [0.75-1.79],0.5084115889881362
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22074,106,0.77 [0.55-1.09],0.1396308610827208
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22045,77,1.13 [0.68-1.87],0.6417924919153275
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23139,1018,1.00 [0.87-1.14],0.9607642285962408
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22390,269,1.57 [1.16-2.11],0.0030161533096357
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22320,72,1.14 [0.67-1.94],0.6251241851951927
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22857,126,0.84 [0.60-1.18],0.3082126628608833
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23121,390,0.92 [0.75-1.12],0.398060047850504
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22471,223,1.02 [0.77-1.36],0.8828837163919796
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23071,145,1.48 [0.99-2.21],0.0572345230975554
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22802,681,0.98 [0.84-1.15],0.8335675953952296
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22628,160,0.89 [0.65-1.22],0.4786652651735603
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20795,3254,1.01 [0.94-1.09],0.7052516890795528
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23076,345,0.97 [0.78-1.22],0.8231039137864983
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23262,188,0.99 [0.73-1.34],0.926103201515381
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22515,547,1.00 [0.83-1.19],0.960319086865172
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22823,92,0.85 [0.57-1.28],0.4409754082922505
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23262,72,0.98 [0.60-1.60],0.9427210249371096
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22096,128,0.86 [0.61-1.20],0.3728474632803625
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22142,174,0.97 [0.71-1.32],0.8429029121966836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21706,164,1.03 [0.74-1.44],0.846825041298834
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22311,63,1.31 [0.73-2.37],0.3631631747759472
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21617,75,1.21 [0.72-2.03],0.4734385125030171
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22234,113,0.71 [0.52-0.98],0.0360474740075391
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22417,296,0.95 [0.75-1.20],0.6640526067640322
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22129,161,0.99 [0.71-1.37],0.9467284012568176
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21639,97,0.98 [0.65-1.47],0.9153221483584224
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21674,132,0.92 [0.65-1.30],0.6285902699093484
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20300,2759,0.99 [0.92-1.08],0.8968867182975463
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22061,93,0.88 [0.59-1.31],0.5246667127746282
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22982,514,0.88 [0.74-1.04],0.1348140423534842
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22549,81,1.08 [0.66-1.76],0.7584329903257779
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22676,208,0.88 [0.67-1.16],0.3673612171175993
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23054,113,1.03 [0.68-1.54],0.8977262657041489
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23230,140,1.08 [0.75-1.57],0.6653710974765297
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23138,118,0.96 [0.66-1.41],0.8533964082723406
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23006,65,0.93 [0.56-1.53],0.7658553840860125
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23011,70,1.11 [0.65-1.87],0.7047913351461699
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23169,1249,0.89 [0.79-0.99],0.0322893341115491
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22867,947,0.88 [0.77-0.99],0.0406739469374558
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22076,156,0.83 [0.61-1.13],0.2413511878218268
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22009,89,0.93 [0.61-1.43],0.734792141279744
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,23084,66,0.77 [0.50-1.20],0.2502032993124021
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23204,186,0.83 [0.63-1.09],0.1740063762775722
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23080,62,0.81 [0.51-1.30],0.380513623507991
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza,20573,158,0.74 [0.56-0.98],0.0384705728265635
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20570,155,0.73 [0.55-0.97],0.0305883754449253
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14362,104,0.85 [0.58-1.25],0.4110556873211308
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,23167,236,1.03 [0.78-1.36],0.8370428911850054
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15577,1715,0.83 [0.75-0.91],4.697772008538563e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15950,1692,0.83 [0.75-0.91],6.884169981771733e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22760,181,0.76 [0.58-0.99],0.0411231361561449
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20520,105,0.73 [0.52-1.03],0.0704607124512087
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bronchiectasis,19522,520,0.70 [0.61-0.81],1.7298293143623162e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19073,71,0.83 [0.53-1.32],0.4376476695297703
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22140,3138,0.81 [0.76-0.86],3.013035800289808e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22048,72,1.08 [0.65-1.80],0.7537325883963296
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,22111,135,0.94 [0.66-1.33],0.7217421283084366
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22985,1643,0.73 [0.67-0.80],2.5949631275771925e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22058,82,0.92 [0.59-1.41],0.6904675560186975
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21111,6130,0.81 [0.77-0.85],5.672794660692144e-18
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22316,340,0.93 [0.75-1.16],0.5264547697065054
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Early onset COPD,21450,108,0.76 [0.56-1.04],0.0908917163841442
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Emphysema,19440,438,0.69 [0.58-0.81],7.067186006439851e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21965,453,0.69 [0.59-0.81],3.811631008652158e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23017,2602,0.73 [0.68-0.79],7.446610106820824e-19
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22009,497,0.68 [0.59-0.79],2.4682802939320804e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Later onset COPD,22755,1535,0.73 [0.67-0.80],1.0706495395617116e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23261,500,0.80 [0.68-0.95],0.0098041509486928
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Nasal polyp,22074,98,0.84 [0.58-1.21],0.3455891138401026
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22990,1305,0.81 [0.73-0.90],5.594959590553949e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,22985,2694,0.75 [0.70-0.80],2.0206574493015527e-16
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22730,754,0.94 [0.81-1.09],0.4104400897081565
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other pleural conditions,20359,68,0.71 [0.47-1.06],0.0933093331335802
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23156,594,0.67 [0.59-0.77],7.035298427214816e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23148,1714,0.76 [0.70-0.83],9.356316707612996e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural effusion,21669,1378,0.72 [0.66-0.79],6.753378367753567e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural plaque,20546,255,0.64 [0.53-0.78],5.548321780019974e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22730,2315,0.73 [0.68-0.78],3.5974944036322055e-18
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23150,389,0.81 [0.67-0.97],0.0246130216759652
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumothorax,20459,168,0.72 [0.55-0.94],0.0146320985610552
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pollen allergy,23265,201,0.98 [0.73-1.31],0.8854102055570451
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,22656,94,0.61 [0.44-0.85],0.0031531975984146
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14329,71,0.65 [0.44-0.97],0.0365415299901652
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22966,1281,0.81 [0.73-0.90],7.431067167613727e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22214,238,1.04 [0.79-1.36],0.7991761277696255
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Viral pneumonia,20717,302,0.75 [0.61-0.92],0.0060667242078855
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22768,240,0.78 [0.62-0.98],0.0356120923630727
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7424,121,0.80 [0.58-1.12],0.1935065125686388
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14740,61,1.09 [0.63-1.89],0.7662830512353768
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute appendicitis,23160,126,0.99 [0.68-1.43],0.9472905451570556
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute gastritis,16167,104,0.99 [0.66-1.50],0.9779008987253626
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,21215,198,0.81 [0.62-1.06],0.1240692131141335
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute peritonitis,22780,113,0.96 [0.65-1.42],0.8440306683889138
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22288,65,0.69 [0.46-1.02],0.0652247904990047
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,16572,509,0.91 [0.76-1.09],0.3007055526091176
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21161,144,0.86 [0.62-1.18],0.3401697601685935
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22851,144,0.86 [0.62-1.19],0.3571567719439152
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholecystitis,21240,223,0.88 [0.67-1.15],0.336985128390678
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholelithiasis,22080,1063,0.81 [0.72-0.91],0.0002605214235485
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic gastritis,16409,346,0.99 [0.79-1.24],0.9095940662915027
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21072,55,0.94 [0.54-1.63],0.8171249038520004
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23134,130,1.10 [0.75-1.61],0.6299752101936708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Coeliac disease,21526,128,0.76 [0.56-1.04],0.0848934480608472
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Collagenous colitis,21510,100,0.76 [0.53-1.08],0.1285636090545486
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23159,159,0.75 [0.57-0.99],0.041011504398729
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Constipation,22990,2143,0.86 [0.80-0.94],0.000707008547671
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn disease,21500,90,0.68 [0.48-0.96],0.0292979918457628
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22922,69,0.70 [0.47-1.04],0.077361598015947
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21492,82,0.71 [0.49-1.04],0.0818793991048535
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Dental caries,22655,191,0.99 [0.73-1.34],0.9676717818001996
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20106,2576,0.91 [0.84-0.98],0.0194642416123465
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of appendix,23191,157,0.97 [0.70-1.34],0.8307224619010645
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of liver,23157,934,0.87 [0.76-0.98],0.0268063355136991
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20694,4631,0.93 [0.88-0.99],0.0172188749929683
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22941,477,1.04 [0.85-1.26],0.7142855098120566
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23184,517,0.81 [0.69-0.95],0.0106159683672657
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22559,95,1.07 [0.69-1.67],0.7670887732221529
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22428,60,1.12 [0.63-1.97],0.7039985031292765
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22939,1541,0.86 [0.78-0.94],0.0018174897503813
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of tongue,22447,97,1.14 [0.73-1.78],0.5780253735767966
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22553,1536,0.80 [0.72-0.87],2.398741683282459e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18483,3804,0.85 [0.80-0.90],1.3228653614939912e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,16316,253,0.80 [0.64-1.01],0.0594774826137072
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23181,206,0.89 [0.68-1.16],0.3836394212293522
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23238,26,1.41 [0.56-3.56],0.4625504047440464
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22375,152,1.12 [0.79-1.60],0.5222055219261221
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14787,108,0.74 [0.53-1.03],0.0787065624809405
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,16628,565,1.04 [0.87-1.24],0.7021672544323481
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastric ulcer,16494,431,0.85 [0.70-1.02],0.0857726359796414
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18752,2689,0.91 [0.84-0.98],0.0179486234553641
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16722,659,0.84 [0.72-0.97],0.021095891259061
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16788,8274,0.94 [0.90-0.98],0.0069814335729119
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,GI-bleeding,22678,1280,0.84 [0.75-0.93],0.0010184335751936
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22510,46,0.99 [0.53-1.84],0.9662072133368452
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15676,1184,0.86 [0.77-0.96],0.0075182994748378
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22294,71,0.85 [0.54-1.35],0.4984074008878104
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Hernia,21202,3672,0.91 [0.85-0.97],0.0036479917932552
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impacted teeth,23242,24,1.35 [0.52-3.51],0.5343622321248583
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impaction of intestines,14756,77,0.69 [0.47-1.02],0.0604183589901495
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Inguinal hernia,18638,1108,0.89 [0.80-1.00],0.0473563019382042
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17654,124,0.77 [0.57-1.04],0.0852808593402314
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14796,117,0.75 [0.54-1.03],0.0785597098227781
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21545,147,0.80 [0.59-1.07],0.1362905915893084
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15198,519,0.85 [0.72-1.01],0.0714734614207004
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23245,341,0.88 [0.71-1.10],0.2620199742161904
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22204,794,0.80 [0.70-0.91],0.0010283930023229
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22510,1100,0.80 [0.71-0.89],0.0001013336077277
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16284,221,0.88 [0.68-1.15],0.3479359098376665
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophagitis,16767,704,0.95 [0.82-1.11],0.5390374305862691
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23223,136,1.13 [0.77-1.65],0.5417258732592622
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17613,83,0.88 [0.58-1.34],0.5538014703853944
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16063,1384,0.87 [0.78-0.96],0.0061513199181139
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21380,363,0.81 [0.66-0.99],0.0354510023613999
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21165,148,0.88 [0.63-1.22],0.4462082085763017
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,16633,1954,0.87 [0.80-0.95],0.0020869890570107
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,20933,6254,0.89 [0.85-0.94],1.0500166041918722e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22409,212,1.12 [0.82-1.51],0.4757259923255525
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of liver,22994,771,0.87 [0.76-1.00],0.0532479095059068
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16835,772,0.91 [0.79-1.05],0.181659121731797
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21233,216,0.72 [0.57-0.92],0.0078029175598735
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23104,437,0.79 [0.66-0.94],0.0072059144235384
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17166,1103,0.89 [0.79-1.00],0.0539372487759333
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22695,1297,0.84 [0.76-0.93],0.0011707449110435
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22645,181,1.04 [0.76-1.44],0.7867806990935522
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16868,2189,0.83 [0.76-0.90],7.078008379006357e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18256,2193,0.95 [0.87-1.04],0.2589820828336046
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22340,117,1.28 [0.83-1.96],0.2635721642736012
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22378,968,0.82 [0.72-0.92],0.0013368562147957
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15131,452,0.75 [0.64-0.89],0.000711619627456
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23234,30,1.55 [0.64-3.74],0.328983860093331
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15302,623,0.77 [0.67-0.89],0.0004376407056067
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21556,158,1.01 [0.72-1.41],0.9577602770523036
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23265,53,0.93 [0.53-1.64],0.8093417270377034
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22458,103,0.93 [0.62-1.39],0.7253897061380143
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Toxic colitis,21491,81,0.91 [0.58-1.43],0.6794199163956619
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16409,346,1.03 [0.82-1.29],0.826406309186224
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,21579,169,0.63 [0.50-0.80],0.0001038798603204
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21544,134,0.78 [0.57-1.07],0.1192073641040772
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Umbilical hernia,17783,253,0.75 [0.61-0.92],0.0065784261306002
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14926,247,0.65 [0.54-0.80],2.3863082680125785e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ventral hernia,17823,293,0.82 [0.66-1.03],0.0831690560950133
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Volvulus,14774,95,0.63 [0.47-0.85],0.0029486608684316
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23170,431,1.04 [0.85-1.27],0.7093422001344535
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22917,65,0.95 [0.58-1.57],0.8432984883888404
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20708,170,1.20 [0.85-1.70],0.3014679381305911
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22641,839,0.81 [0.71-0.92],0.0010439622321319
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21946,144,0.82 [0.60-1.11],0.2043266878018612
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21170,632,0.80 [0.69-0.93],0.0034007470734542
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22933,320,0.77 [0.63-0.94],0.0092962239501917
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23175,562,0.81 [0.69-0.95],0.0079491898354989
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22659,46,1.16 [0.60-2.25],0.6497019888722206
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21666,3749,0.88 [0.83-0.94],0.0001089962814226
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22839,438,0.86 [0.71-1.03],0.0940975623965772
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22706,305,0.86 [0.69-1.07],0.1648479217094793
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22892,1090,0.84 [0.75-0.94],0.0022292342329421
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23256,59,0.82 [0.50-1.35],0.4323746407627147
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20595,57,0.74 [0.46-1.19],0.2151098566237064
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22463,62,0.93 [0.55-1.55],0.7707425329458116
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22920,307,0.77 [0.63-0.95],0.0123073811696959
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21145,607,0.98 [0.83-1.15],0.7874931700333312
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20630,92,0.85 [0.58-1.25],0.4012186878540762
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23188,97,0.83 [0.56-1.22],0.345732414983127
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22042,240,0.82 [0.65-1.05],0.1138456588898776
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23074,222,0.99 [0.75-1.30],0.9159132614516208
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22710,97,0.73 [0.51-1.05],0.0877114504752634
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20617,79,1.40 [0.83-2.39],0.2103123952315069
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22661,2123,0.90 [0.83-0.98],0.0189821374541395
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21190,652,0.96 [0.82-1.12],0.6133496871120329
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20634,96,0.85 [0.58-1.24],0.4009049505244122
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23184,332,0.93 [0.75-1.17],0.5515688585397642
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22689,76,0.94 [0.59-1.50],0.7859089751164406
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23124,272,0.96 [0.75-1.22],0.7273355432328341
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23203,464,1.07 [0.88-1.31],0.5052852652959233
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20665,127,1.53 [0.99-2.35],0.0537307519045398
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20881,343,1.01 [0.81-1.27],0.9291799936220608
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23191,452,1.04 [0.85-1.27],0.6755972825873056
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20878,340,0.68 [0.57-0.81],2.234399058917966e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23250,159,0.67 [0.52-0.86],0.0016167466863686
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19408,82,0.78 [0.52-1.16],0.2179809430371042
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20508,6487,0.93 [0.88-0.98],0.00491879918058
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19087,5066,0.92 [0.87-0.98],0.0065563511304725
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19380,54,0.77 [0.47-1.24],0.2848384213463487
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19311,147,1.13 [0.78-1.63],0.5240927265793802
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19358,194,0.98 [0.72-1.32],0.8815279014547164
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23012,66,1.00 [0.59-1.68],0.9882916375444182
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19318,154,0.76 [0.56-1.02],0.0639914178122631
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15518,1497,0.93 [0.84-1.03],0.17233493591314
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23065,243,0.89 [0.69-1.15],0.3832518933848876
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19758,594,0.94 [0.79-1.11],0.4754891116708913
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18835,8091,0.91 [0.87-0.96],7.613977636031512e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20711,123,0.72 [0.53-0.99],0.0407927402158029
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19511,185,0.72 [0.56-0.93],0.0105422125997873
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19832,506,0.92 [0.77-1.10],0.3715199999240403
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22339,3175,0.88 [0.82-0.95],0.0005392875796073
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19639,313,0.98 [0.78-1.23],0.8550272762772205
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19475,149,0.89 [0.64-1.25],0.5035619885538621
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19439,113,1.13 [0.74-1.71],0.5814646918989845
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22519,102,1.34 [0.83-2.14],0.2292035796389077
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16042,2021,0.84 [0.77-0.91],5.252474733782441e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14825,804,0.76 [0.67-0.86],8.32820039339577e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23179,797,0.75 [0.66-0.85],3.119770120667811e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14098,77,1.10 [0.67-1.82],0.710812110423425
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14325,304,0.92 [0.73-1.17],0.5022556247139558
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19593,267,0.86 [0.68-1.08],0.1922777241854121
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14502,481,0.85 [0.72-1.01],0.0703327839830381
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19246,82,0.93 [0.59-1.46],0.7407934297982209
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19856,692,0.85 [0.73-0.98],0.0285138040081351
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19480,316,0.92 [0.73-1.15],0.4577832179641702
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14470,449,0.85 [0.71-1.02],0.0754143578148634
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19397,71,0.86 [0.55-1.37],0.5311510097109169
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19386,60,1.05 [0.60-1.83],0.8680034741736812
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20673,85,0.83 [0.55-1.24],0.3559288768852899
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22839,2251,0.82 [0.76-0.89],9.260986349085936e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22171,1583,0.80 [0.73-0.88],5.103752556684923e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23102,546,0.82 [0.69-0.96],0.0148940369259029
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17189,3168,0.87 [0.81-0.93],6.0310240167019386e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14064,43,1.83 [0.85-3.97],0.1245014595468736
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19432,106,1.33 [0.84-2.09],0.2232196336308711
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14092,71,0.86 [0.54-1.36],0.5127844928535297
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14159,138,0.93 [0.65-1.33],0.6868347059531964
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20834,246,0.80 [0.63-1.01],0.0606105594298187
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21098,510,0.90 [0.75-1.07],0.2376909453114802
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23253,114,1.16 [0.76-1.76],0.4976725385807717
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21165,2001,0.89 [0.81-0.97],0.0068755651126526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19402,76,0.92 [0.58-1.46],0.724349336524166
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14176,155,0.79 [0.58-1.08],0.1397984333156207
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19960,796,0.88 [0.76-1.01],0.0676007273518433
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16222,2201,0.89 [0.82-0.97],0.008133487252505
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22546,129,1.08 [0.73-1.60],0.6853340238145864
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23265,62,1.00 [0.59-1.70],0.995770309159596
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19405,79,0.99 [0.62-1.59],0.9814807220947914
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20687,1361,0.85 [0.76-0.94],0.0016420827287254
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19436,110,0.69 [0.51-0.94],0.0197647958872878
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16099,2078,0.88 [0.80-0.96],0.0040021399043629
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20706,118,0.79 [0.57-1.11],0.1733812737678106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19363,37,0.62 [0.39-0.97],0.0366314989154538
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19363,199,0.84 [0.64-1.11],0.2191856067358038
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20019,693,0.79 [0.68-0.90],0.0006275881358675
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22910,493,0.83 [0.70-0.98],0.0301168978439725
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19826,662,0.93 [0.79-1.09],0.3499159767716405
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23117,540,0.82 [0.69-0.96],0.0159202831929219
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23251,70,0.61 [0.43-0.85],0.0042335870856818
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19493,167,0.79 [0.60-1.05],0.105411509084514
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18105,900,0.95 [0.83-1.09],0.4894570263464395
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19971,645,0.89 [0.76-1.04],0.1329642236050058
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19607,281,0.96 [0.76-1.22],0.7342936088751622
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14092,71,0.70 [0.46-1.07],0.099273728276799
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17160,3139,0.86 [0.80-0.92],2.301191477344024e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14868,847,0.91 [0.79-1.04],0.1696077786943232
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22792,375,0.91 [0.74-1.12],0.3896899769789175
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23220,81,1.24 [0.74-2.08],0.4161784966964649
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20601,72,0.75 [0.48-1.17],0.2092944615601881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14084,63,0.92 [0.56-1.54],0.763953000642297
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19271,107,0.86 [0.59-1.26],0.4451337622841108
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14574,553,0.79 [0.67-0.93],0.0047061938138362
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19668,342,0.82 [0.68-1.01],0.0573259325072211
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19453,289,0.90 [0.71-1.14],0.3891748145863981
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19433,269,0.91 [0.71-1.17],0.4655401617501663
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16353,68,0.61 [0.43-0.88],0.0079476364838754
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23255,74,0.64 [0.45-0.92],0.0148171826415547
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19886,560,0.79 [0.68-0.92],0.0028324467487044
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22512,95,0.61 [0.45-0.83],0.0013541170547478
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21982,2656,0.87 [0.81-0.94],0.0003110837165325
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19474,148,0.79 [0.58-1.07],0.1228228230234923
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19890,726,0.87 [0.75-1.01],0.0665752394360322
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21894,278,0.81 [0.65-1.02],0.0729994305439403
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19425,261,1.02 [0.78-1.34],0.8603237259374716
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21190,2026,0.85 [0.78-0.93],0.0002866878628145
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20479,1315,0.93 [0.83-1.05],0.2356127298421393
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19389,63,1.12 [0.64-1.96],0.6893267161563016
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22536,119,0.63 [0.47-0.83],0.0013439840302092
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19490,164,1.09 [0.78-1.54],0.6157272675071479
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19416,90,0.86 [0.57-1.30],0.4756462907316053
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14097,76,1.42 [0.82-2.45],0.2079995662183275
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21743,2268,0.78 [0.72-0.84],4.2520143187151056e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9330,26,0.89 [0.40-2.00],0.7800466509328439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11826,33,0.72 [0.39-1.33],0.2956686022454636
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22946,310,0.88 [0.70-1.09],0.2301305621070872
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22738,102,0.86 [0.59-1.24],0.4085960828060004
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21835,2360,0.89 [0.82-0.97],0.0056620786092609
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23042,135,0.90 [0.64-1.28],0.5622450758773501
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22964,416,0.82 [0.69-0.99],0.0425070596580055
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cystitis,19389,301,0.89 [0.71-1.11],0.2993152589539526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Dialysis,19573,98,0.64 [0.47-0.88],0.0050865337276267
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10250,2147,0.91 [0.84-0.99],0.0250652640894755
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11929,136,1.46 [0.95-2.24],0.0825894745996286
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,9344,40,1.16 [0.55-2.42],0.7011317555159071
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9891,587,0.84 [0.71-0.99],0.0369016346638175
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19172,6337,0.89 [0.85-0.93],2.895350401942625e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23005,98,0.65 [0.48-0.89],0.0068090159985085
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,8220,117,1.08 [0.73-1.58],0.7077712709597017
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19545,353,0.79 [0.65-0.95],0.0132511307119796
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9940,1837,0.89 [0.81-0.97],0.0083810982678568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11998,159,1.02 [0.71-1.45],0.9229607278567618
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8227,124,1.03 [0.72-1.49],0.8615830065040568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19174,86,0.98 [0.62-1.53],0.9155325042118
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10343,1039,0.87 [0.77-0.99],0.0303420477222031
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8163,60,0.92 [0.56-1.53],0.7560486653129214
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9343,39,1.03 [0.50-2.15],0.9275695236484222
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23262,88,1.17 [0.73-1.89],0.5166919624973333
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23264,86,0.89 [0.58-1.36],0.5750279879714415
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22063,2975,0.86 [0.80-0.93],6.167826963312263e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20038,950,0.89 [0.78-1.01],0.0659882529087712
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11845,52,2.42 [1.14-5.18],0.0221287474219495
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23188,640,0.80 [0.69-0.93],0.0033343710480193
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8254,151,0.89 [0.66-1.21],0.4641353638437892
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8262,159,0.90 [0.66-1.21],0.4691723887490656
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8255,152,1.11 [0.78-1.56],0.5659548011601294
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23237,87,0.92 [0.60-1.42],0.7067918369624453
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21452,2364,0.83 [0.77-0.90],2.6418331631001608e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11921,82,1.10 [0.66-1.84],0.7044494239023555
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9373,69,1.04 [0.61-1.78],0.8947922432750808
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9441,137,0.90 [0.63-1.29],0.5600068342805058
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9356,52,0.94 [0.52-1.69],0.8301497896676985
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9407,103,0.86 [0.58-1.28],0.4555406387881038
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19609,417,0.81 [0.67-0.96],0.0178180949021442
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22752,204,0.71 [0.56-0.90],0.0050672440768003
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9430,126,1.13 [0.75-1.71],0.5565544643973059
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9329,25,0.69 [0.35-1.36],0.2866656409748376
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9515,211,0.79 [0.60-1.03],0.0858020733408464
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9397,93,0.79 [0.53-1.16],0.2269736150002007
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9515,211,1.05 [0.77-1.44],0.7540556450744247
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22955,48,0.65 [0.41-1.01],0.053827895471526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8258,155,1.03 [0.74-1.43],0.8811000987066032
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22982,3790,0.87 [0.81-0.92],9.085444006826469e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19286,94,1.03 [0.66-1.60],0.8983602209208971
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19657,182,0.80 [0.61-1.06],0.1244039000594154
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22677,41,0.82 [0.46-1.45],0.4962412361951285
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19358,270,0.92 [0.72-1.16],0.4750686994026742
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23033,397,0.87 [0.72-1.06],0.1652906959190396
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9341,37,0.73 [0.39-1.37],0.3314452992944648
